Tag: antibody
Research on Treatments for Alzheimer’s Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category)
TOKYO, Apr 18, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that “The Research on Treatments for Alzheimer’s Disease Based on its...
Breaking News
Passage of the Amendment to the Advanced Regenerative Biotech Act a Positive Catalyst for Korean and Japanese Cell Therapy Companies
Legislation Puts Renewed Focus on Next-Generation NK Cell Therapies
New York, Feb 7, 2024 - (Plato Data) - On Thursday February 2, 2024, the bio...
DNA Nanobots Closes Pre-seed Investment Round to Grow BioPharma Partner Program
Platform company uses antibody-targeted DNA nanoparticles to deliver a wide range of therapeutic payloads to desired tissue.
COLUMBUS, Ohio–(BUSINESS WIRE)–#RNA–DNA Nanobots, a leader in the...
Focused ultrasound plus plaque-reducing drugs could slow Alzheimer’s progression – Physics World
<a href="https://coingenius.news/wp-content/uploads/2024/01/focused-ultrasound-plus-plaque-reducing-drugs-could-slow-alzheimers-progression-physics-world-3.jpg" data-fancybox data-src="https://coingenius.news/wp-content/uploads/2024/01/focused-ultrasound-plus-plaque-reducing-drugs-could-slow-alzheimers-progression-physics-world-3.jpg" data-caption="Deliver the drugs Researchers at the West Virginia University Rockefeller Neuroscience Institute, shown in the MRI...
Fish & Richardson Elevates 20 Attorneys to Principal
MINNEAPOLIS–(BUSINESS WIRE)–Fish & Richardson is pleased to announce that 20 attorneys have been elevated to principal, effective January 1, 2024. This interdisciplinary class brings...
USA Solid Tumor Therapeutics Market Outlook to 2028 – Field of Oncology is Moving Towards more Personalized Treatment – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “USA Solid Tumor Therapeutics Market Outlook to 2028” report has been added to ResearchAndMarkets.com’s offering.
The USA Solid Tumor Therapeutics Market refers to...
This Week’s Awesome Tech Stories From Around the Web (Through December 16)
Google DeepMind Used a Large Language Model to Solve an Unsolvable Math ProblemWill Douglas Heaven | MIT Technology Review“In a paper published in Nature...
Ultrasound innovations enable pain-free vaccination, monitor muscle dynamics in real time – Physics World
The Acoustics 2023 Sydney conference, co-hosted by the Acoustical Society of America and the Australian...
“LEQEMBI Intravenous Infusion”Lecanemab) for the Treatment of Alzheimer’s Disease to be Launched in Japan on December 20
TOKYO and CAMBRIDGE, Mass., Dec 14, 2023 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that humanized anti- soluble aggregated...
SimBioSys Presents New Data for Breast Cancer Personalized Medicine Platforms at the 46th Annual San Antonio Breast Cancer Symposium
CHICAGO–(BUSINESS WIRE)–SimBioSys, a TechBio company unlocking the power of spatial biophysics with artificial intelligence (AI) and data science to redefine precision medicine for cancer...
IPA Announces Closing of $1.265 Million Public Offering of Common Shares
VICTORIA, British Columbia–(BUSINESS WIRE)–$IPA #AI–ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”), today announced the closing of its $1.265 million underwritten...
AstraZeneca bets $247M AI can create cancer antibody
Pharma giant AstraZeneca has signed a $247 million deal with Ai drug creation company Absci to develop an antibody designed to fight cancer.
The collaboration...
Boehringer Ingelheim signs up with IBM for AI therapy
Boehringer Ingelheim is the latest pharma company to turn to AI in the hunt for new treatments and therapies.
The German company announced earlier this...
Latest Intelligence
